Copy Link Print Information

Tunicamycin

156 Cited Publications
Customer Review

Based on 156 publication(s) in Google Scholar

Tunicamycin is a mixture of homologous nucleoside antibiotic that inhibits N-linked glycosylation and blocks GlcNAc phosphotransferase (GPT). Tunicamycin causes accumulation of unfolded proteins in cell endoplasmic reticulum (ER) and induces ER stress, and causes blocking of DNA synthesis and cell cycle arrest in G1 phase. Tunicamycin inhibits gram-positive bacteria, yeasts, fungi, and viruses and has anti-cancer activity.Tunicamycin increases exosome release in cervical cancer cells.

For research use only. We do not sell to patients.

  • Purity: 99.96%
  • CAS No.: 11089-65-9
  • Formula: C39H64N4O16
  • Molecular Weight:844.94 (n=10)
  • Storage:
    Powder   -20°C, 3 years ; In solvent   -80°C, 6 months , -20°C, 1 month
  • Tunicamycin Chemical Structure
    Tunicamycin Chemical Structure
  • Experimental Validation Results for Tunicamycin
  • Experimental Validation Results for Tunicamycin
  • Experimental Validation Results for Tunicamycin
  • Experimental Validation Results for Tunicamycin
  • Experimental Validation Results for Tunicamycin
  • Experimental Validation Results for Tunicamycin
  • Experimental Validation Results for Tunicamycin
  • Experimental Validation Results for Tunicamycin
  • Experimental Validation Results for Tunicamycin
  • Experimental Validation Results for Tunicamycin
  • Experimental Validation Results for Tunicamycin
  • Experimental Validation Results for Tunicamycin
CAS No.: 11089-65-9
Size
Price
Stock
Quantity
Amount: USD 0.00
Please select quantity
or
or

* Please select Quantity before adding items.

To place orders, for customer services and technical support, please contact: MedChemExpress USA

Tel: 609-228-6898 E-mail: [email protected] [email protected]

Data Download

To place orders, for customer services and technical support, please contact:

609-228-6898
[email protected] [email protected]
Find Your Local Distributor Your local distributor: Hycultec GmbHHycultec
  • Biological Activity
  • Chemical Information
  • Solvent & Solubility
  • Purity & Documentation
  • References
  • Help & FAQs
You May Still Need
Top Publications Citing

Use of MCE Products

Publications Citing Use of MedChemExpress (MCE) Tunicamycin

More
Customer Validation & Images
WBCell Proliferation/Viability AssayCell Imaging/StainingFlow Cytometry
  • WB
  • WB
  • Cell Imaging/Staining
  • Flow Cytometry
  • WB
  • Cell Proliferation/Viability Assay
  • Cell Imaging/Staining
  • WB
  • Flow Cytometry
  • WB
  • WB
  • Cell Proliferation/Viability Assay

All Antibiotic Isoforms

More

All Aminotransferases (Transaminases) Isoforms

More
Keywords
100 mg

Get Quote In-stock

Please select quantity
Amount: USD 0.00
Sign in to MedChemExpress Sign In
Register
Sign in to MedChemExpress
Register New Account

At least 6 characters

Personalize your experience, you are currently not signed in. For a better experience, please create an online profile, you can:

Obtain points redemption prizes
Check out faster
Add multiple shipping locations
View orders
Assay Types
  • Tunicamycin Chemical Structure
    Tunicamycin Chemical Structure
    1/16
  • 1/16

    Tunicamycin purchased from MedChemExpress. Usage Cited in: Nat Genet. 2025 Mar;57(3):680-693. [Abstract]

    Customer Validation
     PD-L1 WT or mutants were transfected into SK-MEL-28 cells and treated with tunicamycin (2.5  μM) for 24 hours. PD-L1 expression was analyzed by immunoblotting (n = 3 independent experiments).

  • 1/16

    Tunicamycin purchased from MedChemExpress. Usage Cited in: Inflammation. 2025 Oct;48(5):3146-3155. [Abstract]

    Customer Validation
     The melanocytes were treated with TM (3 μM), thapsigargin (1 μM), or DTT (1 mM) for 24 h to induce ER stress.

  • 1/16

    Tunicamycin purchased from MedChemExpress. Usage Cited in: Inflammation. 2025 Oct;48(5):3146-3155. [Abstract]

    Customer Validation
     The melanocytes were treated with TM (3 μM), thapsigargin (1 μM), or DTT (1 mM) for 24 h to induce ER stress.

  • 1/16

    Tunicamycin purchased from MedChemExpress. Usage Cited in: Inflammation. 2025 Oct;48(5):3146-3155. [Abstract]

    Customer Validation
     The melanocytes were treated with TM (3 μM), thapsigargin (1 μM), or DTT (1 mM) for 24 h to induce ER stress. ER stress induced an increase in the apoptosis of melanocytes.

  • 1/16

    Tunicamycin purchased from MedChemExpress. Usage Cited in: Int J Oral Sci. 2024 Jul 1;16(1):47. [Abstract]

    Customer Validation
     Deglycosylation of EREG enhanced the turnover of EREG. HN4 and 293-EREG cells were treated with 10 μg/mL tunicamycin for 24 h followed by pulse-chase with 100 μg/mL cycloheximide.

  • 1/16

    Tunicamycin purchased from MedChemExpress. Usage Cited in: Sci Adv. 2023 May 24;9(21):eadg8156. [Abstract]

    Customer Validation
     Cell death quantification by IncuCyte of wild-type (WT) or YFP-Parkin MEFs after 24 hours of treatment with 1 μM tunicamycin in combination or not with 40 μM qVD.

  • 1/16

    Tunicamycin purchased from MedChemExpress. Usage Cited in: Redox Biol. 2023 Jul:63:102765. [Abstract]

    Customer Validation
     SA-β-gal staining was performed MLE12 cells were treated with TM (0.25 μg/mL) for 24 hours.

  • 1/16

    Tunicamycin purchased from MedChemExpress. Usage Cited in: Nature. 2020 Mar;579(7799):433-437. [Abstract]

    Customer Validation
     Clonal HAP1 knockout and stably reconstituted cells were treated as indicated (CCCP, 20 μM, 9 h; Tunicamycin, HY-A0098, 10 μM, 9 h; Oligomycin (OM), 9 h; CDDO, Bardoxolone, HY-14909, 2.5 μM, 11 h; GTPP, HY-102007A, 10 μM, 11 h) and analysed by immunoblotting.

  • 1/16

    Tunicamycin purchased from MedChemExpress. Usage Cited in: Nature. 2020 Mar;579(7799):433-437. [Abstract]

    Customer Validation
     HAP1 CHOPNeon cells of the indicated genotypes were treated for 9 h (CCCP, 20 μM; Tunicamycin, HY-A0098, 10 μM; CDDO, Bardoxolone, HY-14909, 2.5 μM) or 12 h (GTPP, HY-102007A, 10 μM) and analysed by flow cytometry. Per genotype and treatment, the CHOPNeonsignal was normalized to its DMSO control and statistical significance is indicated compared to identically treated wild-type cells (mean ± s.d. of n = 3 independent experiments; one-way ANOVA with Dunnett’s multiple comparisons correction).

  • 1/16

    Tunicamycin purchased from MedChemExpress. Usage Cited in: Autophagy. 2021 Jun;17(6):1426-1447. [Abstract]

    Customer Validation
     NRK cells were pre-treated with 10 μM CQ for 8 h, and followed by 0.1 μg/mL tunicamycin treatment for 6 h.

  • 1/16

    Tunicamycin purchased from MedChemExpress. Usage Cited in: Cell Death Dis. 2018 May 22;9(6):604. [Abstract]

    Customer Validation
     Western blot analysis of ER stress-related proteins after PPI treatment for 48 h in both pH 7.4 and pH 6.5 conditions. Cells treated with Thapsigargin (TG, 0.5 and 1 μM) or Tunicamycin (Tu, 2.5, 5 and 10 μg/mL) for 24 h served as positive controls.

  • 1/16

    Tunicamycin purchased from MedChemExpress. Usage Cited in: PLoS Biol. 2018 Oct 18;16(10):e2006483.  [Abstract]

    Customer Validation
     SK-Hep1 cells stably expressing EV or Flag-PGM1 are treated with or without 0.1 ug/mL Tunicamycin, and cell proliferation is measured.

  • Tunicamycin